Author:
Paulose Sefy A.,Sherman Suzanne W.,Dagi Glass Lora R.,Suh Leejee H.
Reference10 articles.
1. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial;Thaci;Lancet,2016
2. Dupixent (Dupilumab) [package Insert],2017
3. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis;Simpson;N Engl J Med,2016
4. Adverse events of Dupilumab in adults with moderate-to-severe atopic dermatitis: a meta-analysis;Ou;Int Immunopharmacol,2018
5. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids: a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial;Blauvelt;Lancet,2017
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献